|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenues | ||
| Products | ||
| Services | ||
| Total revenues | ||
| Cost of goods | ||
| Cost of services | ||
| Gross profit | ||
| Selling, general, and administrative expenses | ||
| Goodwill impairment loss | ||
| Operating income | ||
| Loss on extinguishment of debt | ||
| Interest expense, net | ||
| Income (loss) from continuing operations before income taxes | ||
| Income tax expense (benefit) | ||
| Net income (loss) from continuing operations | ||
| Income from discontinued operations, net of income taxes | ||
| Net income (loss) | ||
| Net loss attributable to noncontrolling interests included in continuing operations | ||
| Net income (loss) attributable to BrightSpring Health Services, Inc. and subsidiaries | ||
| Net income (loss) per common share (Note 10): | ||
| Basic income (loss) per share attributable to common shareholders: | ||
| Continuing operations | ||
| Discontinued operations | ||
| Net income (loss) per share | ||
| Diluted income (loss) per share attributable to common shareholders: | ||
| Continuing operations | ||
| Discontinued operations | ||
| Net income (loss) per share | ||
| Weighted average shares outstanding: | ||
| Basic | ||
| Diluted |
Loading...
